LumiraDx’s COVID-19 Antigen Test Expanded to Include Screening of Asymptomatic Individuals
LumiraDx announced that the intended use for its FDA EUA-authorized SARS-CoV-2 Antigen Test has been expanded to include asymptomatic individuals.
Read More
Search Results for: point-of-care
Strategic COVID-19 Testing Could Prevent Distancing, Shutdowns
Making diagnostic tests for SARS-CoV-2 faster or more available could reduce reliance on costly interventions, such as distancing and shutdowns.
Read More
New Device Offers Noninvasive Hemoglobin Measurement for People of Color
A wearable device that “reads” blood through the skin could reduce racial disparities in blood measurements.
Read More
BD Collaborates with U.S. Government to Develop COVID-19 Diagnostics
BARDA will invest $24.7 million for BD to develop five new COVID-19 combination diagnostic tests for core labs, hospitals, and point-of-care locations.
Read More
Dotz Nano to Showcase Mega-Diagnostic Platform
Dotz Nano will introduce its Mega-Diagnostic Platform for en masse, rapid diagnosis of COVID-19 at the point of care.
Read More